International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER)

Abstract Background Real-world data on non-vitamin K oral anticoagulants (NOACs) are essential in determining whether evidence from randomised controlled clinical trials translate into meaningful clinical benefits for patients in everyday practice. RIVER (RIVaroxaban Evaluation in Real life setting)...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Jan Beyer-Westendorf, A. John Camm, Keith A. A. Fox, Jean-Yves Le Heuzey, Sylvia Haas, Alexander G. G. Turpie, Saverio Virdone, Ajay K. Kakkar, for the RIVER Registry Investigators
Formato: Artigo
Idioma:Inglês
Publicado: BMC 2019-04-01
Series:Thrombosis Journal
Assuntos:
Anticoagulant
Antithrombotic
Atrial fibrillation
Outcomes
Registry
Rivaroxaban
Acceso en liña:http://link.springer.com/article/10.1186/s12959-019-0195-7
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
Cargando...

Títulos similares